NEW YORK (GenomeWeb) – Device firm EKF Diagnostics said that it is considering plans to split into two separate companies — one focused on point-of-care testing and the other on laboratory diagnostics.

As part of this plan, the company said it would delist its shares from the AIM market and seek listings for each new company separately in a market to be determined.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.